'Time machine' offers new pancreatic cancer drug testing approach

Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated.


Click here for original story, ‘Time machine’ offers new pancreatic cancer drug testing approach


Source: Phys.org